Genetic Analyses of Male Breast Cancer in Israel
Ronit Shiri‐Sverdlov(Maastricht University), Eitan Friedman(University of Pennsylvania), E. Dagan(Technion – Israel Institute of Technology), Ruth Gershoni Baruch(Rambam Health Care Campus), Revital Bruchim Bar Sade(Sheba Medical Center), Iris Barshack(Tel Aviv University), Meora Feinmesser(Rabin Medical Center), Arié Figer(Ontario Institute for Cancer Research), Galit Hirsh-Yehezkel(Sheba Medical Center)
Cited by 41
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987